Literature DB >> 28990132

OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Assia Mairi1,2, Alix Pantel2,3, Albert Sotto2, Jean-Philippe Lavigne4,5, Aziz Touati1.   

Abstract

The emergence of carbapenem-resistant enterobacterial species poses a serious threat to public health worldwide. OXA-48-type carbapenem-hydrolyzing class D β-lactamases are widely distributed among Enterobacteriaceae, with significant geographical differences. To date, 11 OXA-48-like variants have been identified, with classical OXA-48 being the most widespread. These enzymes show high-level hydrolytic activity against penicillins and low-level hydrolysis towards carbapenems. Since the first description of the OXA-48 carbapenemase in Turkey, bacterial strains producing the enzyme have been extensively reported in nosocomial and community outbreaks in many parts of the word, particularly in the Mediterranean area and European countries. The rapid spread of Enterobacteriaceae producing OXA-48-like enzymes in different ecosystems has become a serious issue recently. The number of reservoirs for such organisms is increasing, not only in hospitals, but also in the community, among animals (e.g., livestock, companion animals, and wildlife) and in the environment. This review aims to summarize the main characteristics of the OXA-48-type carbapenemases, covering genetic and enzymatic traits, their epidemiology, clonality and associated genes, correlation with extended-spectrum β-lactamases (ESBLs) or plasmidic AmpC (pAmpC) in different bacterial species worldwide.

Entities:  

Keywords:  Carbapenemase; Enterobacteriaceae; Environment; Niches; OXA-48-like; Persistence

Mesh:

Substances:

Year:  2017        PMID: 28990132     DOI: 10.1007/s10096-017-3112-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  238 in total

1.  NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.

Authors:  L Dortet; L Poirel; F Al Yaqoubi; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2012-03-08       Impact factor: 8.067

2.  Derepressed transfer properties leading to the efficient spread of the plasmid encoding carbapenemase OXA-48.

Authors:  Anaïs Potron; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

Review 3.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

4.  Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.

Authors:  Jesús Oteo; Adriana Ortega; Rosa Bartolomé; Germán Bou; Carmen Conejo; Marta Fernández-Martínez; Juan José González-López; Laura Martínez-García; Luis Martínez-Martínez; María Merino; Elisenda Miró; Marta Mora; Ferran Navarro; Antonio Oliver; Álvaro Pascual; Jesús Rodríguez-Baño; Guillermo Ruiz-Carrascoso; Patricia Ruiz-Garbajosa; Laura Zamorano; Verónica Bautista; María Pérez-Vázquez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

5.  Multidrug Resistance in Quinolone-Resistant Gram-Negative Bacteria Isolated from Hospital Effluent and the Municipal Wastewater Treatment Plant.

Authors:  Ivone Vaz-Moreira; Ana Rita Varela; Thamiris V Pereira; Romário C Fochat; Célia M Manaia
Journal:  Microb Drug Resist       Date:  2015-10-15       Impact factor: 3.431

6.  Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae.

Authors:  Anaïs Potron; Patrice Nordmann; Emilie Lafeuille; Zaina Al Maskari; Fatma Al Rashdi; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

7.  Origin of OXA-181, an emerging carbapenem-hydrolyzing oxacillinase, as a chromosomal gene in Shewanella xiamenensis.

Authors:  Anaïs Potron; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

8.  Carbapenemase-producing enterobacteriaceae in Spain in 2012.

Authors:  Jesús Oteo; David Saez; Verónica Bautista; Sara Fernández-Romero; Juan Manuel Hernández-Molina; María Pérez-Vázquez; Belén Aracil; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem.

Authors:  Murat Kasap; Sinem Torol; Fetiye Kolayli; Devrim Dundar; Haluk Vahaboglu
Journal:  J Enzyme Inhib Med Chem       Date:  2012-07-30       Impact factor: 5.051

10.  Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.

Authors:  Te Din Huang; Pierre Bogaerts; Catherine Berhin; Martin Hoebeke; Caroline Bauraing; Youri Glupczynski
Journal:  Euro Surveill       Date:  2017-05-11
View more
  45 in total

1.  A Cost-Effective Method for Identifying Enterobacterales with OXA-181.

Authors:  Gisele Peirano; Yasufumi Matsumura; Diego Nobrega; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

Review 2.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

Review 3.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

4.  OXA-48-Like-Producing Klebsiella pneumoniae in Southern Spain in 2014-2015.

Authors:  Jesús Machuca; Lorena López-Cerero; Felipe Fernández-Cuenca; Laura Mora-Navas; Concepción Mediavilla-Gradolph; Inmaculada López-Rodríguez; Álvaro Pascual
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

5.  High-Level Carbapenem Resistance in OXA-232-Producing Raoultella ornithinolytica Triggered by Ertapenem Therapy.

Authors:  Alina Iovleva; Roberta T Mettus; Christi L McElheny; Marissa P Griffith; Mustapha M Mustapha; A William Pasculle; Ryan K Shields; Vaughn S Cooper; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

6.  Activity of Imipenem-Relebactam and Comparator Agents against Genetically Characterized Isolates of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Matthew C Canver; Michael J Satlin; Lars F Westblade; Barry N Kreiswirth; Liang Chen; Amy Robertson; Kathy Fauntleroy; Marisa La Spina; Katrina Callan; Stephen G Jenkins
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

Review 7.  Treatment of Infections by OXA-48-Producing Enterobacteriaceae.

Authors:  Adam Stewart; Patrick Harris; Andrew Henderson; David Paterson
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

8.  Dissemination of Carbapenemases (OXA-48, NDM and VIM) Producing Enterobacteriaceae Isolated from the Mohamed VI University Hospital in Marrakech, Morocco.

Authors:  Souad Loqman; Nabila Soraa; Seydina M Diene; Jean-Marc Rolain
Journal:  Antibiotics (Basel)       Date:  2021-04-26

9.  Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae.

Authors:  Olga Pacios; Laura Fernández-García; Ines Bleriot; Lucía Blasco; Mónica González-Bardanca; María López; Felipe Fernández-Cuenca; Jesús Oteo; Álvaro Pascual; Luis Martínez-Martínez; Pilar Domingo-Calap; Germán Bou; María Tomás
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

10.  Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of Enterobacterales Expressing Extended-Spectrum β-Lactamases and Serine Carbapenemases.

Authors:  Cassandra L Chatwin; Jodie C Hamrick; Robert E L Trout; Cullen L Myers; Susan M Cusick; William J Weiss; Mark E Pulse; Luigi Xerri; Christopher J Burns; Gregory Moeck; Denis M Daigle; Kaitlyn John; Tsuyoshi Uehara; Daniel C Pevear
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.